Ivey Business School (Canada)
-
23andMe: Which Business Model(s)?
Paul W. Beamish, Vineet Gupta, Brigitte McIntyreCase IVEY-W33345-EStrategyIn June 2021, 23andMe completed their IPO with the VG Acquisition Corp, a special-purpose acquisition company. Due to the COVID-19 pandemic, there was more interest in genomics, as its value at scale had been demonstrated through many of the public health vaccine sequencing initiatives. Given these favorable market conditions and access to capital, was this the right time for 23andMe to shift their business model away from a consumer genetic test...Starting at €8.20